|
OMIM |
Link |
Information gain |
01 |
|
PAND1
|
[NCBI]
|
0.0019149
|
|
|
OFC1
|
[NCBI]
|
0.00185601
|
|
|
MAFD2
|
[NCBI]
|
0.00176273
|
|
|
constricting bands, congenital
|
[NCBI]
|
0.00158051
|
|
|
apnea, obstructive sleep
|
[NCBI]
|
0.000756289
|
|
|
urogenital adysplasia, hereditary
|
[NCBI]
|
0.000749964
|
|
|
dyskinesia, familial, with facial myokymia
|
[NCBI]
|
0.000622573
|
|
|
malaria, mild, susceptibility to
|
[NCBI]
|
0.000622573
|
|
|
breast cancer, 11-22 translocation associated
|
[NCBI]
|
0.000622573
|
|
|
testicular germ cell tumor 1
|
[NCBI]
|
0.000622573
|
|
|
aneurysm, intracranial berry, 1
|
[NCBI]
|
0.00058255
|
|
|
HSCR9
|
[NCBI]
|
0.00052433
|
|
|
IBD6
|
[NCBI]
|
0.00052433
|
|
|
autoimmune thyroid disease, susceptibility to, 2
|
[NCBI]
|
0.00052433
|
|
|
migraine with or without aura, susceptibility to, 1
|
[NCBI]
|
0.000483433
|
|
|
fatty metamorphosis of viscera
|
[NCBI]
|
0.000461184
|
|
|
breast cancer
|
[NCBI]
|
0.000459755
|
|
|
spinal muscular atrophy, childhood, proximal, autosomal dominant
|
[NCBI]
|
0.000414706
|
|
|
coronary heart disease, susceptibility to, 2
|
[NCBI]
|
0.000414706
|
|
|
deafness, progressive high-tone neural
|
[NCBI]
|
0.000414706
|
|
|
VRNI
|
[NCBI]
|
0.0003785
|
|
|
pena-shokeir syndrome, type i
|
[NCBI]
|
0.000378116
|
|
|
SCZD10
|
[NCBI]
|
0.000378047
|
|
|
GBY
|
[NCBI]
|
0.000378047
|
|
|
APOE
|
[NCBI]
|
0.000362162
|
|
|
hodgkin disease, x-linked pseudoautosomal
|
[NCBI]
|
0.000347875
|
|
|
nephrolithiasis, calcium oxalate
|
[NCBI]
|
0.000347875
|
|
|
HD
|
[NCBI]
|
0.00034673
|
|
|
alzheimer disease 8
|
[NCBI]
|
0.000322313
|
|
|
short rib-polydactyly syndrome, type iii
|
[NCBI]
|
0.000322313
|
|
|
gonadal dysgenesis, xy type
|
[NCBI]
|
0.000280762
|
|
|
AMCN
|
[NCBI]
|
0.000280762
|
|
|
AUTS6
|
[NCBI]
|
0.000263462
|
|
|
IBD5
|
[NCBI]
|
0.000263462
|
|
|
poland syndrome
|
[NCBI]
|
0.00024791
|
|
|
telomere length, mean leukocyte
|
[NCBI]
|
0.00024791
|
|
|
ST8
|
[NCBI]
|
0.000233813
|
|
|
mesothelioma, malignant
|
[NCBI]
|
0.000233813
|
|
|
IBGC1
|
[NCBI]
|
0.000233813
|
|
|
FEB1
|
[NCBI]
|
0.000233813
|
|
|
AD
|
[NCBI]
|
0.000230146
|
|
|
CRC
|
[NCBI]
|
0.000227882
|
|
|
AFP
|
[NCBI]
|
0.000224507
|
|
|
coffin-siris syndrome
|
[NCBI]
|
0.000220946
|
|
|
HFM
|
[NCBI]
|
0.000218199
|
|
|
MDD
|
[NCBI]
|
0.000211398
|
|
|
BRCA2
|
[NCBI]
|
0.000211384
|
|
|
KLK3
|
[NCBI]
|
0.000211097
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
0.000207306
|
|
|
IDDM
|
[NCBI]
|
0.000198228
|
|
|
hodgkin lymphoma
|
[NCBI]
|
0.000178708
|
|
|
neural tube defects
|
[NCBI]
|
0.000162336
|
|
|
VUR1
|
[NCBI]
|
0.000161764
|
|
|
BRCA1
|
[NCBI]
|
0.000150154
|
|
|
MVP
|
[NCBI]
|
0.000146813
|
|
|
diaphragmatic hernia, congenital
|
[NCBI]
|
0.000146813
|
|
|
hashimoto thyroiditis
|
[NCBI]
|
0.000139981
|
|
|
melanoma-pancreatic cancer syndrome
|
[NCBI]
|
0.0001273
|
|
|
myeloproliferative syndrome, transient
|
[NCBI]
|
0.000121633
|
|
|
aplastic anemia
|
[NCBI]
|
0.00011113
|
|
|
AT
|
[NCBI]
|
0.00011073
|
|
|
lung cancer
|
[NCBI]
|
0.000108749
|
|
|
omphalocele
|
[NCBI]
|
0.000105061
|
|
|
HSAS
|
[NCBI]
|
0.000104342
|
|
|
DWS
|
[NCBI]
|
0.000101225
|
|
|
RA
|
[NCBI]
|
9.80858e-05
|
|
|
systemic lupus erythematosus, susceptibility to, 9
|
[NCBI]
|
9.71048e-05
|
|
|
neuropathy, hereditary sensory, atypical
|
[NCBI]
|
9.71048e-05
|
|
|
hemophagocytic lymphohistiocytosis, familial, 1
|
[NCBI]
|
8.83017e-05
|
|
|
LFS1
|
[NCBI]
|
8.817e-05
|
|
|
APC
|
[NCBI]
|
8.759e-05
|
|
|
factor v deficiency
|
[NCBI]
|
8.70808e-05
|
|
|
EGF
|
[NCBI]
|
8.41784e-05
|
|
|
kaposi sarcoma
|
[NCBI]
|
8.11039e-05
|
|
|
amyotrophic lateral sclerosis-parkinsonism/dementia complex 1
|
[NCBI]
|
8.11039e-05
|
|
|
RB1
|
[NCBI]
|
8.06386e-05
|
|
|
CRP
|
[NCBI]
|
7.6899e-05
|
|
|
sickle cell anemia
|
[NCBI]
|
7.25482e-05
|
|
|
bladder cancer
|
[NCBI]
|
7.09686e-05
|
|
|
MG
|
[NCBI]
|
7.01709e-05
|
|
|
thalamic degeneration, symmetric infantile
|
[NCBI]
|
6.94887e-05
|
|
|
fibromuscular dysplasia of arteries
|
[NCBI]
|
6.94887e-05
|
|
|
diabetes mellitus, transient neonatal, 3
|
[NCBI]
|
6.94887e-05
|
|
|
pancreatic carcinoma
|
[NCBI]
|
6.88333e-05
|
|
|
PEE1
|
[NCBI]
|
6.71075e-05
|
|
|
GLC3A
|
[NCBI]
|
6.49229e-05
|
|
|
HLA-C
|
[NCBI]
|
6.41099e-05
|
|
|
PD
|
[NCBI]
|
6.27395e-05
|
|
|
klippel-trenaunay-weber syndrome
|
[NCBI]
|
6.11601e-05
|
|
|
THBD
|
[NCBI]
|
6.02993e-05
|
|
|
tracheoesophageal fistula with or without esophageal atresia
|
[NCBI]
|
5.91634e-05
|
|
|
fetal akinesia syndrome, x-linked
|
[NCBI]
|
5.91634e-05
|
|
|
diabetic nephropathy, susceptibility to
|
[NCBI]
|
5.91634e-05
|
|
|
native american myopathy
|
[NCBI]
|
5.91634e-05
|
|
|
metachromatic leukodystrophy
|
[NCBI]
|
5.76131e-05
|
|
|
DMD
|
[NCBI]
|
5.72466e-05
|
|
|
protein c deficiency, congenital thrombotic disease due to
|
[NCBI]
|
5.27329e-05
|
|
|
platelet disorder, familial, with associated myeloid malignancy
|
[NCBI]
|
5.25135e-05
|
|
|
isotretinoin embryopathy-like syndrome
|
[NCBI]
|
5.25135e-05
|
|
|
earlobe crease
|
[NCBI]
|
4.76092e-05
|
|
|
microcephaly with spastic quadriplegia
|
[NCBI]
|
4.76092e-05
|
|
|
macrocephaly, benign familial
|
[NCBI]
|
4.76092e-05
|
|
|
budd-chiari syndrome
|
[NCBI]
|
4.76092e-05
|
|
|
BWS
|
[NCBI]
|
4.69176e-05
|
|
|
COMT
|
[NCBI]
|
4.67776e-05
|
|
|
PCTT
|
[NCBI]
|
4.58564e-05
|
|
|
drug metabolism, poor, cyp2d6-related
|
[NCBI]
|
4.58564e-05
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
4.37645e-05
|
|
|
tibial hemimelia
|
[NCBI]
|
4.37329e-05
|
|
|
PMF
|
[NCBI]
|
4.37329e-05
|
|
|
serpentine fibula-polycystic kidney syndrome
|
[NCBI]
|
4.37329e-05
|
|
|
AR
|
[NCBI]
|
4.29221e-05
|
|
|
T
|
[NCBI]
|
4.05764e-05
|
|
|
WT1
|
[NCBI]
|
4.05653e-05
|
|
|
GBS
|
[NCBI]
|
4.0536e-05
|
|
|
hypospadias, autosomal
|
[NCBI]
|
4.0536e-05
|
|
|
atrial septal defect with atrioventricular conduction defects
|
[NCBI]
|
4.0536e-05
|
|
|
CJD
|
[NCBI]
|
4.03506e-05
|
|
|
fragile x mental retardation syndrome
|
[NCBI]
|
3.83964e-05
|
|
|
hermaphroditism, true
|
[NCBI]
|
3.78219e-05
|
|
|
vitiligo
|
[NCBI]
|
3.78219e-05
|
|
|
PJS
|
[NCBI]
|
3.77029e-05
|
|
|
F2
|
[NCBI]
|
3.74893e-05
|
|
|
DYT1
|
[NCBI]
|
3.70992e-05
|
|
|
VHL
|
[NCBI]
|
3.67334e-05
|
|
|
CMM
|
[NCBI]
|
3.57883e-05
|
|
|
CMT1B
|
[NCBI]
|
3.5633e-05
|
|
|
osteogenesis imperfecta, type iia
|
[NCBI]
|
3.5633e-05
|
|
|
CPAF
|
[NCBI]
|
3.54688e-05
|
|
|
vitamin k-dependent clotting factors, combined deficiency of, 1
|
[NCBI]
|
3.54688e-05
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
3.49706e-05
|
|
|
severe cutaneous adverse reaction, susceptibility to
|
[NCBI]
|
3.3396e-05
|
|
|
aryl hydrocarbon hydroxylase inducibility
|
[NCBI]
|
3.3396e-05
|
|
|
situs inversus viscerum
|
[NCBI]
|
3.3396e-05
|
|
|
VDR
|
[NCBI]
|
3.25649e-05
|
|
|
APOA1
|
[NCBI]
|
3.24533e-05
|
|
|
TH
|
[NCBI]
|
3.23938e-05
|
|
|
CTSD
|
[NCBI]
|
3.18939e-05
|
|
|
MTR
|
[NCBI]
|
3.16134e-05
|
|
|
cirrhosis, familial
|
[NCBI]
|
3.1547e-05
|
|
|
PFHB1A
|
[NCBI]
|
3.1547e-05
|
|
|
MTC
|
[NCBI]
|
2.9881e-05
|
|
|
abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism
|
[NCBI]
|
2.9881e-05
|
|
|
HPE2
|
[NCBI]
|
2.9881e-05
|
|
|
medulloblastoma
|
[NCBI]
|
2.9881e-05
|
|
|
IHPS1
|
[NCBI]
|
2.9881e-05
|
|
|
PRL
|
[NCBI]
|
2.97785e-05
|
|
|
homocystinuria
|
[NCBI]
|
2.89885e-05
|
|
|
CPI
|
[NCBI]
|
2.86513e-05
|
|
|
chondrodysplasia punctata, autosomal dominant
|
[NCBI]
|
2.83674e-05
|
|
|
GFAP
|
[NCBI]
|
2.83562e-05
|
|
|
IDE
|
[NCBI]
|
2.76695e-05
|
|
|
CYP1A1
|
[NCBI]
|
2.71458e-05
|
|
|
FRA16A
|
[NCBI]
|
2.69826e-05
|
|
|
complement component 7 deficiency
|
[NCBI]
|
2.69826e-05
|
|
|
BHD
|
[NCBI]
|
2.69826e-05
|
|
|
PNDM
|
[NCBI]
|
2.69826e-05
|
|
|
CCK
|
[NCBI]
|
2.63798e-05
|
|
|
SHBG
|
[NCBI]
|
2.58936e-05
|
|
|
HSCR1
|
[NCBI]
|
2.57897e-05
|
|
|
ADLTE
|
[NCBI]
|
2.57081e-05
|
|
|
MCPH1
|
[NCBI]
|
2.57081e-05
|
|
|
leprosy, susceptibility to
|
[NCBI]
|
2.57081e-05
|
|
|
nondisjunction
|
[NCBI]
|
2.57081e-05
|
|
|
GDXY
|
[NCBI]
|
2.56971e-05
|
|
|
EPHX1
|
[NCBI]
|
2.56971e-05
|
|
|
ALDH2
|
[NCBI]
|
2.50829e-05
|
|
|
SLE
|
[NCBI]
|
2.49644e-05
|
|
|
ARL11
|
[NCBI]
|
2.44007e-05
|
|
|
TOX3
|
[NCBI]
|
2.44007e-05
|
|
|
menkes disease
|
[NCBI]
|
2.43191e-05
|
|
|
CRH
|
[NCBI]
|
2.40128e-05
|
|
|
longevity
|
[NCBI]
|
2.34342e-05
|
|
|
neural tube defects, folate-sensitive
|
[NCBI]
|
2.34342e-05
|
|
|
RP
|
[NCBI]
|
2.24434e-05
|
|
|
MNS
|
[NCBI]
|
2.24129e-05
|
|
|
STIP1
|
[NCBI]
|
2.23937e-05
|
|
|
IGKV1OR2108
|
[NCBI]
|
2.23937e-05
|
|
|
ZNF202
|
[NCBI]
|
2.23937e-05
|
|
|
KIR2DL5
|
[NCBI]
|
2.23937e-05
|
|
|
CH25H
|
[NCBI]
|
2.23937e-05
|
|
|
lynch syndrome i
|
[NCBI]
|
2.21812e-05
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
2.20087e-05
|
|
|
HRPT1
|
[NCBI]
|
2.14571e-05
|
|
|
CBAVD
|
[NCBI]
|
2.14571e-05
|
|
|
brugada syndrome 1
|
[NCBI]
|
2.14571e-05
|
|
|
PI
|
[NCBI]
|
2.13886e-05
|
|
|
PROCR
|
[NCBI]
|
2.09316e-05
|
|
|
MTUS1
|
[NCBI]
|
2.09052e-05
|
|
|
frank-ter haar syndrome
|
[NCBI]
|
2.09052e-05
|
|
|
saitohin
|
[NCBI]
|
2.09052e-05
|
|
|
PSORS1
|
[NCBI]
|
2.06157e-05
|
|
|
autism
|
[NCBI]
|
2.05904e-05
|
|
|
porphyria, congenital erythropoietic
|
[NCBI]
|
2.05601e-05
|
|
|
stroke, ischemic
|
[NCBI]
|
2.05601e-05
|
|
|
mucopolysaccharidosis type iiib
|
[NCBI]
|
2.05601e-05
|
|
|
epidermolysis bullosa letalis
|
[NCBI]
|
2.05601e-05
|
|
|
NAT1
|
[NCBI]
|
2.03435e-05
|
|
|
CEACAM5
|
[NCBI]
|
2.03307e-05
|
|
|
MLX
|
[NCBI]
|
1.97219e-05
|
|
|
histidinemia
|
[NCBI]
|
1.97158e-05
|
|
|
EBR1
|
[NCBI]
|
1.97158e-05
|
|
|
mismatch repair cancer syndrome
|
[NCBI]
|
1.97158e-05
|
|
|
UGT1A1
|
[NCBI]
|
1.90901e-05
|
|
|
mannosidosis, alpha b, lysosomal
|
[NCBI]
|
1.89192e-05
|
|
|
aortic aneurysm, abdominal
|
[NCBI]
|
1.89192e-05
|
|
|
epidermolysis bullosa with pyloric atresia
|
[NCBI]
|
1.89192e-05
|
|
|
sialuria, finnish type
|
[NCBI]
|
1.89192e-05
|
|
|
VEGF
|
[NCBI]
|
1.88473e-05
|
|
|
CA3
|
[NCBI]
|
1.87403e-05
|
|
|
niemann-pick disease, type a
|
[NCBI]
|
1.81661e-05
|
|
|
TGD
|
[NCBI]
|
1.81661e-05
|
|
|
diastrophic dysplasia
|
[NCBI]
|
1.81661e-05
|
|
|
IL10
|
[NCBI]
|
1.79755e-05
|
|
|
HSD17B1
|
[NCBI]
|
1.79022e-05
|
|
|
PODXL
|
[NCBI]
|
1.79022e-05
|
|
|
HGF
|
[NCBI]
|
1.7742e-05
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
1.75869e-05
|
|
|
acyl-coa dehydrogenase, medium-chain, deficiency of
|
[NCBI]
|
1.74526e-05
|
|
|
alcohol dependence
|
[NCBI]
|
1.74526e-05
|
|
|
FGF20
|
[NCBI]
|
1.71712e-05
|
|
|
GRIK1
|
[NCBI]
|
1.71712e-05
|
|
|
SOD3
|
[NCBI]
|
1.71712e-05
|
|
|
MYLK
|
[NCBI]
|
1.71712e-05
|
|
|
ehlers-danlos syndrome, type iv, autosomal dominant
|
[NCBI]
|
1.67755e-05
|
|
|
CPX
|
[NCBI]
|
1.67755e-05
|
|
|
CR2
|
[NCBI]
|
1.65235e-05
|
|
|
GSTT1
|
[NCBI]
|
1.65235e-05
|
|
|
MTHFR
|
[NCBI]
|
1.63169e-05
|
|
|
hepatocellular carcinoma
|
[NCBI]
|
1.61318e-05
|
|
|
mucopolysaccharidosis type ii
|
[NCBI]
|
1.53516e-05
|
|
|
SPDA1
|
[NCBI]
|
1.49346e-05
|
|
|
usher syndrome, type i
|
[NCBI]
|
1.49346e-05
|
|
|
PPP1R1B
|
[NCBI]
|
1.49336e-05
|
|
|
MSR1
|
[NCBI]
|
1.44901e-05
|
|
|
NPAS2
|
[NCBI]
|
1.44901e-05
|
|
|
ATRX
|
[NCBI]
|
1.43768e-05
|
|
|
testicular tumors
|
[NCBI]
|
1.43768e-05
|
|
|
AHCY
|
[NCBI]
|
1.40795e-05
|
|
|
CGA
|
[NCBI]
|
1.40795e-05
|
|
|
TNNI3
|
[NCBI]
|
1.40795e-05
|
|
|
AURKA
|
[NCBI]
|
1.40795e-05
|
|
|
PCSK9
|
[NCBI]
|
1.40795e-05
|
|
|
homocysteinemia
|
[NCBI]
|
1.38436e-05
|
|
|
graves disease
|
[NCBI]
|
1.38436e-05
|
|
|
CPB2
|
[NCBI]
|
1.3678e-05
|
|
|
ELAC2
|
[NCBI]
|
1.33398e-05
|
|
|
ADIPOR1
|
[NCBI]
|
1.33398e-05
|
|
|
CYP2C9
|
[NCBI]
|
1.33398e-05
|
|
|
CYBA
|
[NCBI]
|
1.33398e-05
|
|
|
MAOA
|
[NCBI]
|
1.31225e-05
|
|
|
SCZD
|
[NCBI]
|
1.30312e-05
|
|
|
KCNQ1OT1
|
[NCBI]
|
1.30043e-05
|
|
|
RNASEL
|
[NCBI]
|
1.30043e-05
|
|
|
ALD
|
[NCBI]
|
1.28612e-05
|
|
|
human immunodeficiency virus type 1, susceptibility to
|
[NCBI]
|
1.28451e-05
|
|
|
FCHL
|
[NCBI]
|
1.28451e-05
|
|
|
SGBS1
|
[NCBI]
|
1.28451e-05
|
|
|
gastric cancer
|
[NCBI]
|
1.28451e-05
|
|
|
BHMT
|
[NCBI]
|
1.26883e-05
|
|
|
IL6R
|
[NCBI]
|
1.26883e-05
|
|
|
IL6ST
|
[NCBI]
|
1.26883e-05
|
|
|
ACE
|
[NCBI]
|
1.24881e-05
|
|
|
SPG3A
|
[NCBI]
|
1.23768e-05
|
|
|
PGL1
|
[NCBI]
|
1.23768e-05
|
|
|
CMH
|
[NCBI]
|
1.23201e-05
|
|
|
NCSTN
|
[NCBI]
|
1.21068e-05
|
|
|
CCND1
|
[NCBI]
|
1.2028e-05
|
|
|
CDKN2A
|
[NCBI]
|
1.18713e-05
|
|
|
DRD3
|
[NCBI]
|
1.1838e-05
|
|
|
IL1RN
|
[NCBI]
|
1.15822e-05
|
|
|
HLA-DQB1
|
[NCBI]
|
1.15822e-05
|
|
|
F12
|
[NCBI]
|
1.15822e-05
|
|
|
DBH
|
[NCBI]
|
1.15822e-05
|
|
|
RET
|
[NCBI]
|
1.14921e-05
|
|
|
ANXA5
|
[NCBI]
|
1.13381e-05
|
|
|
malaria, susceptibility to
|
[NCBI]
|
1.10814e-05
|
|
|
HLA-DRB1
|
[NCBI]
|
1.08814e-05
|
|
|
NKX2E
|
[NCBI]
|
1.08814e-05
|
|
|
SRD5A2
|
[NCBI]
|
1.08814e-05
|
|
|
MS
|
[NCBI]
|
1.07898e-05
|
|
|
ACH
|
[NCBI]
|
1.07898e-05
|
|
|
nijmegen breakage syndrome
|
[NCBI]
|
1.06827e-05
|
|
|
PMS2
|
[NCBI]
|
1.06672e-05
|
|
|
PON1
|
[NCBI]
|
1.05147e-05
|
|
|
ADH2
|
[NCBI]
|
1.04615e-05
|
|
|
AGER
|
[NCBI]
|
1.04493e-05
|
|
|
DYT1
|
[NCBI]
|
1.02636e-05
|
|
|
GPX1
|
[NCBI]
|
1.02636e-05
|
|
|
ABCB1
|
[NCBI]
|
1.0256e-05
|
|
|
FTD
|
[NCBI]
|
1.02091e-05
|
|
|
CF
|
[NCBI]
|
1.0169e-05
|
|
|
PCNA
|
[NCBI]
|
1.01376e-05
|
|
|
PWS
|
[NCBI]
|
9.94485e-06
|
|
|
XPC
|
[NCBI]
|
9.88938e-06
|
|
|
NOS2A
|
[NCBI]
|
9.88938e-06
|
|
|
DISC1
|
[NCBI]
|
9.88938e-06
|
|
|
DPYD
|
[NCBI]
|
9.7121e-06
|
|
|
ADH5
|
[NCBI]
|
9.7121e-06
|
|
|
GCDH
|
[NCBI]
|
9.7121e-06
|
|
|
IL1B
|
[NCBI]
|
9.7121e-06
|
|
|
CST3
|
[NCBI]
|
9.7121e-06
|
|
|
GPC3
|
[NCBI]
|
9.7121e-06
|
|
|
TGFBR2
|
[NCBI]
|
9.7121e-06
|
|
|
STAT4
|
[NCBI]
|
9.7121e-06
|
|
|
CRY1
|
[NCBI]
|
9.54082e-06
|
|
|
ENPP1
|
[NCBI]
|
9.37517e-06
|
|
|
TERC
|
[NCBI]
|
9.37517e-06
|
|
|
HLA-B
|
[NCBI]
|
9.37517e-06
|
|
|
BMD
|
[NCBI]
|
9.2308e-06
|
|
|
GRPR
|
[NCBI]
|
9.21483e-06
|
|
|
hemophilia a
|
[NCBI]
|
9.02382e-06
|
|
|
GHRL
|
[NCBI]
|
8.90888e-06
|
|
|
IGKC
|
[NCBI]
|
8.90888e-06
|
|
|
ICAM1
|
[NCBI]
|
8.90888e-06
|
|
|
TFPI
|
[NCBI]
|
8.83677e-06
|
|
|
MYO7A
|
[NCBI]
|
8.76273e-06
|
|
|
CYP3A4
|
[NCBI]
|
8.62082e-06
|
|
|
LTA
|
[NCBI]
|
8.62082e-06
|
|
|
ESR2
|
[NCBI]
|
8.62082e-06
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
8.36028e-06
|
|
|
NOD2
|
[NCBI]
|
8.34884e-06
|
|
|
EDMD
|
[NCBI]
|
8.2728e-06
|
|
|
DM2
|
[NCBI]
|
8.2728e-06
|
|
|
spermatogenic failure, nonobstructive, y-linked
|
[NCBI]
|
8.2728e-06
|
|
|
FY
|
[NCBI]
|
8.21838e-06
|
|
|
HFE
|
[NCBI]
|
8.15758e-06
|
|
|
MMP3
|
[NCBI]
|
7.96768e-06
|
|
|
LPA
|
[NCBI]
|
7.84712e-06
|
|
|
APOB
|
[NCBI]
|
7.60798e-06
|
|
|
DMD
|
[NCBI]
|
7.42996e-06
|
|
|
MFS
|
[NCBI]
|
7.41115e-06
|
|
|
TCF7L2
|
[NCBI]
|
7.39368e-06
|
|
|
CTSC
|
[NCBI]
|
7.39368e-06
|
|
|
IFNG
|
[NCBI]
|
7.39368e-06
|
|
|
WAS
|
[NCBI]
|
7.39343e-06
|
|
|
MPO
|
[NCBI]
|
7.38176e-06
|
|
|
COL3A1
|
[NCBI]
|
7.1826e-06
|
|
|
BRRS
|
[NCBI]
|
7.14197e-06
|
|
|
glioma of brain, familial
|
[NCBI]
|
7.14197e-06
|
|
|
PRNP
|
[NCBI]
|
7.09384e-06
|
|
|
RP2
|
[NCBI]
|
7.0806e-06
|
|
|
HS
|
[NCBI]
|
6.98085e-06
|
|
|
CFB
|
[NCBI]
|
6.88326e-06
|
|
|
CYP2D6
|
[NCBI]
|
6.88326e-06
|
|
|
down syndrome
|
[NCBI]
|
6.88247e-06
|
|
|
EIG
|
[NCBI]
|
6.81116e-06
|
|
|
B2M
|
[NCBI]
|
6.78775e-06
|
|
|
FLNA
|
[NCBI]
|
6.78775e-06
|
|
|
AN2
|
[NCBI]
|
6.6315e-06
|
|
|
MHS1
|
[NCBI]
|
6.6315e-06
|
|
|
A2M
|
[NCBI]
|
6.51295e-06
|
|
|
PLP1
|
[NCBI]
|
6.51295e-06
|
|
|
DCC
|
[NCBI]
|
6.42504e-06
|
|
|
IGF2
|
[NCBI]
|
6.33886e-06
|
|
|
RPGR
|
[NCBI]
|
6.33886e-06
|
|
|
EPO
|
[NCBI]
|
6.20094e-06
|
|
|
CVID
|
[NCBI]
|
6.16929e-06
|
|
|
bullous erythroderma ichthyosiformis congenita of brocq
|
[NCBI]
|
6.15377e-06
|
|
|
NOS3
|
[NCBI]
|
6.09021e-06
|
|
|
PF4
|
[NCBI]
|
6.05989e-06
|
|
|
CAT
|
[NCBI]
|
6.04816e-06
|
|
|
CFTR
|
[NCBI]
|
5.99692e-06
|
|
|
CYP19A1
|
[NCBI]
|
5.93215e-06
|
|
|
VWS
|
[NCBI]
|
5.70629e-06
|
|
|
ACHE
|
[NCBI]
|
5.69386e-06
|
|
|
ANG
|
[NCBI]
|
5.42184e-06
|
|
|
MC4R
|
[NCBI]
|
5.28704e-06
|
|
|
NF1
|
[NCBI]
|
5.14868e-06
|
|
|
MKS1
|
[NCBI]
|
5.087e-06
|
|
|
MLH1
|
[NCBI]
|
5.03044e-06
|
|
|
TP53
|
[NCBI]
|
4.83476e-06
|
|
|
SNCA
|
[NCBI]
|
4.78971e-06
|
|
|
HRG
|
[NCBI]
|
4.73183e-06
|
|
|
prostate cancer
|
[NCBI]
|
4.5243e-06
|
|
|
AQP1
|
[NCBI]
|
4.50883e-06
|
|
|
VHL
|
[NCBI]
|
4.45511e-06
|
|
|
IS1
|
[NCBI]
|
4.37747e-06
|
|
|
GBA
|
[NCBI]
|
4.24785e-06
|
|
|
HLA-A
|
[NCBI]
|
4.24785e-06
|
|
|
TD1
|
[NCBI]
|
4.17782e-06
|
|
|
gaucher disease, type i
|
[NCBI]
|
4.17782e-06
|
|
|
COL2A1
|
[NCBI]
|
4.14855e-06
|
|
|
antithrombin iii deficiency
|
[NCBI]
|
4.05197e-06
|
|
|
BCHE
|
[NCBI]
|
4.04397e-06
|
|
|
ornithine transcarbamylase deficiency, hyperammonemia due to
|
[NCBI]
|
4.01262e-06
|
|
|
MEN2A
|
[NCBI]
|
4.01262e-06
|
|
|
SOD2
|
[NCBI]
|
3.8425e-06
|
|
|
GH1
|
[NCBI]
|
3.73382e-06
|
|
|
MBL2
|
[NCBI]
|
3.55573e-06
|
|
|
LCAT
|
[NCBI]
|
3.47272e-06
|
|
|
MYOC
|
[NCBI]
|
3.44349e-06
|
|
|
glycogen storage disease ii
|
[NCBI]
|
3.40157e-06
|
|
|
F3
|
[NCBI]
|
3.34295e-06
|
|
|
ADA
|
[NCBI]
|
3.32542e-06
|
|
|
IFNA1
|
[NCBI]
|
3.28872e-06
|
|
|
AVSD
|
[NCBI]
|
3.26049e-06
|
|
|
RBP1
|
[NCBI]
|
3.21415e-06
|
|
|
COL1A1
|
[NCBI]
|
3.1056e-06
|
|
|
PPARG
|
[NCBI]
|
3.07028e-06
|
|
|
IBD1
|
[NCBI]
|
2.99142e-06
|
|
|
ATM
|
[NCBI]
|
2.96678e-06
|
|
|
CFH
|
[NCBI]
|
2.96678e-06
|
|
|
PKD1
|
[NCBI]
|
2.93309e-06
|
|
|
UCP2
|
[NCBI]
|
2.93309e-06
|
|
|
alopecia, androgenetic
|
[NCBI]
|
2.86317e-06
|
|
|
MAPT
|
[NCBI]
|
2.83431e-06
|
|
|
osteogenesis imperfecta, type i
|
[NCBI]
|
2.61866e-06
|
|
|
PNPLA6
|
[NCBI]
|
2.55747e-06
|
|
|
INSR
|
[NCBI]
|
2.49964e-06
|
|
|
BL
|
[NCBI]
|
2.41955e-06
|
|
|
SMA1
|
[NCBI]
|
2.38942e-06
|
|
|
LPL
|
[NCBI]
|
2.32598e-06
|
|
|
UCP1
|
[NCBI]
|
2.2545e-06
|
|
|
GNRH1
|
[NCBI]
|
2.07466e-06
|
|
|
CGD
|
[NCBI]
|
1.97353e-06
|
|
|
BLM
|
[NCBI]
|
1.97353e-06
|
|
|
EGFR
|
[NCBI]
|
1.94961e-06
|
|
|
TG
|
[NCBI]
|
1.88514e-06
|
|
|
WRN
|
[NCBI]
|
1.87791e-06
|
|
|
ACADM
|
[NCBI]
|
1.80781e-06
|
|
|
TSD
|
[NCBI]
|
1.73986e-06
|
|
|
TF
|
[NCBI]
|
1.67417e-06
|
|
|
apc gene
|
[NCBI]
|
1.62484e-06
|
|
|
PTH
|
[NCBI]
|
1.62026e-06
|
|
|
APP
|
[NCBI]
|
1.53015e-06
|
|
|
POMC
|
[NCBI]
|
1.52581e-06
|
|
|
HP
|
[NCBI]
|
1.4856e-06
|
|
|
TS
|
[NCBI]
|
1.44159e-06
|
|
|
TNFRSF11B
|
[NCBI]
|
1.42575e-06
|
|
|
CDK4
|
[NCBI]
|
1.40528e-06
|
|
|
GIST
|
[NCBI]
|
1.3161e-06
|
|
|
OXT
|
[NCBI]
|
1.2888e-06
|
|
|
polycystic kidneys
|
[NCBI]
|
1.21696e-06
|
|
|
AS
|
[NCBI]
|
1.21696e-06
|
|
|
SST
|
[NCBI]
|
1.19519e-06
|
|
|
GTS
|
[NCBI]
|
1.1581e-06
|
|
|
APS1
|
[NCBI]
|
1.15127e-06
|
|
|
DGS
|
[NCBI]
|
1.10323e-06
|
|
|
temporal arteritis
|
[NCBI]
|
9.32344e-07
|
|
|
ALB
|
[NCBI]
|
8.31461e-07
|
|
|
SCA1
|
[NCBI]
|
7.85138e-07
|
|
|
G6PD
|
[NCBI]
|
7.34976e-07
|
|
|
FA
|
[NCBI]
|
7.29378e-07
|
|
|
ADHD
|
[NCBI]
|
5.86673e-07
|
|
|
AKR1B1
|
[NCBI]
|
5.80424e-07
|
|
|
ACPP
|
[NCBI]
|
5.28239e-07
|
|
|
SERPINA6
|
[NCBI]
|
4.95255e-07
|
|
|
FGFR3
|
[NCBI]
|
4.71433e-07
|
|
|
BDNF
|
[NCBI]
|
4.70973e-07
|
|
|
TNF
|
[NCBI]
|
4.66002e-07
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
4.19493e-07
|
|
|
HBA1
|
[NCBI]
|
3.97464e-07
|
|
|
TLR4
|
[NCBI]
|
2.96462e-07
|
|
|
IP
|
[NCBI]
|
2.86517e-07
|
|
|
CD
|
[NCBI]
|
2.63897e-07
|
|
|
TYMS
|
[NCBI]
|
2.46564e-07
|
|
|
EV
|
[NCBI]
|
1.80042e-07
|
|
|
PPARA
|
[NCBI]
|
1.73414e-07
|
|
|
CTGF
|
[NCBI]
|
1.69751e-07
|
|
|
MJD
|
[NCBI]
|
1.5269e-07
|
|
|
INS
|
[NCBI]
|
9.92861e-08
|
|
|
SLC6A4
|
[NCBI]
|
9.92861e-08
|
|
|
amyloidosis vi
|
[NCBI]
|
4.23261e-08
|
|
|
STAT3
|
[NCBI]
|
3.03415e-08
|
|
|
PMD
|
[NCBI]
|
2.76917e-08
|
|
|
OSM
|
[NCBI]
|
2.72498e-08
|
|
|
HBB
|
[NCBI]
|
2.63238e-08
|
|
|
TTR
|
[NCBI]
|
2.47194e-08
|
|
|
LAM
|
[NCBI]
|
1.75504e-08
|
|
|
PCD
|
[NCBI]
|
1.75504e-08
|
|
|
PGR
|
[NCBI]
|
1.61145e-09
|
|